DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
The US government is suing Gilead for patent infringement, claiming that the pharmaceutical company has been piggybacking on public research to earn billions from its HIV drugs.
The US Court of Appeals for the Second Circuit has dismissed a Russian pharmaceutical company’s antitrust claims against Roche.
Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.
German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.
The US International Trade Commission is investigating certain endoscopic devices after a German medical devices company accused Japanese optical products manufacturer Olympus of patent infringement.
US President Donald Trump has nominated a new commissioner of the Food and Drug Administration.
An individual who manufactured and sold counterfeit fentanyl has been sentenced to 30 years in prison by a US court.
Latham and Watkins has unveiled two new IP partners and one counsel as part of its annual appointments and promotions.
The Board of Appeal of the European Patent Office has issued new communication summarising issues that will be discussed at a hearing on whether the EPO erred in its revocation of a patent owned by the Broad Institute.